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Key questions
What is already known about this subject?
 ► CT is pivotal in guiding patient selection, valve sizing 
and determining procedural risk assessment prior 
to transcatheter aortic valve implantation (TAVI). It is 
recognised that TAVI practice varies according to in-
stitutional infrastructure and physician training and 
preference but the extent to which practice varies 
is not known.
What does this study add?
 ► This study provides an overview of current CT- TAVI 
acquisition, reporting and dissemination of findings 
in the UK and serves as a point of reference for indi-
viduals and organisations seeking to evaluate their 
own methods of performing CT- TAVI.
How might this impact on clinical practice?
 ► Greater insight into current national trends in CT- 
TAVI practice may inform changes to individual in-
stitutional protocols and facilitate ‘hub and spoke’ 
communication between TAVI and non- TAVI centres.
AbstrAct
Objective This cross- sectional observational study sought 
to describe variations in CT in the context of transcatheter 
aortic valve implantation (CT- TAVI) as currently performed 
in the UK.
Methods 408 members of the British Society of 
Cardiovascular Imaging were invited to complete a 27- 
item online CT- TAVI survey.
Results 47 responses (12% response rate) were received 
from 40 cardiac centres, 23 (58%) of which performed 
TAVI on- site (TAVI centres). Only six respondents (13%) 
performed high- volume activity (>200 scans per year) 
compared with 13 (28%) performing moderate (100–200 
scans per year) and 27 (59%) performing low (0–99 scans 
per year) volume activity. Acquisition protocols varied 
(41% retrospective, 12% prospective with wide padding, 
47% prospective with narrow padding), as did the phase 
of reporting (45% systolic, 37% diastolic, 11% both, 6% 
unreported). Median dose length product was 675  mGy. 
cm (IQR 477–954  mGy. cm). Compared with non- TAVI 
centres, TAVI centres were more likely to report minimum 
iliofemoral luminal diameter (n=25, 96% vs n=7, 58%, 
p=0.003) and optimal tube angulation for intervention 
(n=12, 46% vs n=1, 8%, p=0.02).
Conclusions This national survey formally describes 
current CT- TAVI practice in the UK. High- volume activity 
was only present at one in seven cardiac CT centres. There 
is wide variation in scan acquisition, scan reporting and 
radiation dose exposure in cardiac CT centres.
IntROduCtIOn
Percutaneous transcatheter aortic valve 
implantation (TAVI) for severe aortic valve 
disease has become widespread over the 
past decade. The improved safety profile of 
TAVI compared with cardiothoracic surgery 
in lower risk cohorts is likely to result in the 
further expansion of TAVI in the coming 
years.1 Historically, cardiothoracic surgery 
has offered direct visualisation of the cardiac 
anatomy to plan and implement appropriate 
valve replacement, but the advent of TAVI has 
necessitated a preprocedural road map of the 
cardiac anatomy to facilitate the safe deploy-
ment of appropriately sized aortic valve pros-
theses.2 The isotropic resolution of cardiac 
CT has made it a critical investigation in 
assessing valve anatomy when deciding which 
patients may be suitable for TAVI.3
While standards of practice exist for cardiac 
CT in the assessment of coronary artery 
disease,4 there is a paucity of data regarding 
the optimal image acquisition protocols and 
standardised reporting criteria for CT in 
TAVI (CT- TAVI) scans. Recently, the Society 
of Cardiovascular Computed Tomography 
has published an expert consensus document 
highlighting the need for standardisation 
of nomenclature and measurements using 
CT- TAVI.5 However, whether these interna-
tional recommendations reflect the current 
practice of CT- TAVI acquisition and reporting 
in the UK is unknown. Additionally, while 
diagnostic dose reference levels are available 
for most CT procedures, the acceptable limits 
of ionising radiation for CT- TAVI are yet to be 
established.6
This study aimed to survey members of a 
national cardiovascular imaging society who 
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perform CT- TAVI to assess the variability in scan acquisi-
tion, reporting and dissemination of findings.
MetHOds
survey population
All 408 members of the British Society of Cardiovascular 
Imaging (BSCI) were invited to complete a 27- item online 
survey (online supplementary file 1) ( www. surveymonkey. 
com) in April 2018. The BSCI is composed of members 
of the cardiovascular imaging community, which serves as 
a Specialist Advisory Group on matters related to cardi-
ovascular imaging to the British Cardiovascular Society 
and Royal College of Radiologists, UK. While standards 
of practice for the training and reporting of CT coronary 
angiography (CTCA) have been produced by the BSCI in 
line with recommendations from the Francis report,7 no 
standards of practice exist for the training and reporting 
of CT- TAVI scans. Survey questions were constructed to 
assess the level of activity, and variability in CT- TAVI prac-
tice, across centres in the UK currently delivering this 
service for the National Health Service (NHS) England, 
NHS Wales, NHS Scotland, and Health and Social Care 
in Northern Ireland. Patients and the public were not 
involved in the design of the survey.
Items surveyed
All participants were surveyed individually to prevent 
collaboration bias between institutions. All responses 
were included in the analysis. Parameters recorded 
included the type of institution (centres performing 
TAVI (TAVI centre) vs those without a TAVI (non- TAVI 
centre) programme), make of CT scanner, total number 
of CT- TAVI scans performed annually, scan acquisition 
protocol, use of medication (beta- blockers) during scan 
acquisition, contrast volume and radiation doses of the 
last five scans performed, structured reporting metrics of 
the aortic valve annulus and vascular access, and access to 
and distribution of findings to the TAVI multidisciplinary 
team.
statistical analysis
Continuous variables are reported as mean±SD or 
median and IQR, for normally and non- normally distrib-
uted variables, respectively. The survey questions were 
built using skip logic to save respondents time and 
ensure a high response rate. The skip or ‘conditional 
branching’ pattern varies depending on the respondent’s 
answers and this results in incomplete data sets for some 
survey questions. Consequently, categorical variables are 
presented as counts and percentages of the total number 
of complete responses for each question. The survey was 
designed as a descriptive exploration of current practices 
and thus not designed nor powered to detect specific 
differences. Where differences in practice were apparent, 
continuous variables were assessed with Student’s t- test 
and categorical variables were assessed with Fisher’s exact 
test in cases where χ2 test was not valid. A p value <0.05 
was taken to indicate statistical significance. The analysis 
was carried out in SPSS (IBM SPSS Statistics for Macin-
tosh, V.25.0. IBM).
Results
Ct-tAVI annualised activity in tAVI and non-tAVI centres
Forty- seven responses (12% response rate) from 40 cardiac 
centres in the UK were received (figure 1). Fifty- three per 
cent of respondents (n=25/47) were radiologists and 47% 
(n=22/47) were cardiologists with a subspecialty interest 
in cardiac CT. Most respondents worked in centres which 
included a TAVI programme on- site (n=30/47, 63.8%) 
(figure 1). Annualised volume of CT- TAVI activity for 
acquisition and reporting varied considerably (n=1, no 
data provided), 59% of respondents (n=27/46) reported 
a low volume of activity (<100 CT- TAVI scans per annum), 
compared with 28% (n=13/46) performing a moderate 
level of activity (100–200 scans per annum) and 13% 
(n=6/46) performing a high level of scan activity (>200 
scans per annum) (figure 1). Respondents working 
in TAVI centres performed more CT- TAVI activities 
per annum compared with those in non- TAVI centres 
(p<0.001).
scan acquisition and radiation dose in tAVI and non-tAVI 
centres
Overall, retrospective ECG- gated acquisitions were 
performed by 41% (n=14/34) of respondents, compared 
with 47% (n=16/34) performing prospective ECG- 
triggered acquisitions with narrow padding, and 12% 
(n=4/34) performing prospective ECG- triggered acqui-
sitions with wide padding (figure 2). There was no differ-
ence between TAVI and non- TAVI centres regarding 
acquisition protocol (p=0.72). Median contrast volumes 
and dose length product (DLP) of the five most recently 
performed CT- TAVI scans did not vary between TAVI and 
non- TAVI centres (table 1). The median CT- TAVI DLP 
across all participating centres was 675  mGy. cm (IQR 
477–954  mGy. cm). Using wide padding (30%–80% R- R 
interval) more than doubles the CT- TAVI DLP from 
423 to 921  mGy. cm for prospectively triggered CT- TAVI, 
whereas retrospective ECG gating yielded a median DLP 
of 882  mGy. cm (table 1). Beta- blockade was administered 
by 15% (n=7/47) of respondents. Furthermore, cardiol-
ogists were significantly more likely to administer beta- 
blockers compared with radiologists (n=6/25, 24% vs 
n=1/22, 5%, p=0.01).
Ct-tAVI reporting in tAVI and non-tAVI centres
Thirty- five centres provided parameters on reporting. 
Two centres acquired scans but did not analyse preproce-
dural measurements (6%). Forty- five per cent (n=16/35) 
of centres reported systolic- only aortic annulus meas-
urements, 37% (n=13/35) reported diastolic- only aortic 
annulus measurements and 11% (n=4/35) reported 
both systolic and diastolic aortic annulus measurements. 
Five centres did not report the phase of reconstruction. 
With respect to the detailed assessment of aortic root 
measurements, there were no standard metrics which 
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Figure 1 Geographical distribution of survey respondents. Cardiac CT centres from England, Scotland, Wales and Northern 
Ireland provided survey data (A). Sixty- five per cent of respondents worked in centres that provided a transcatheter aortic valve 
implantation (TAVI) programme (B). Annualised activity varied across centres with non- TAVI centres performing <100 scans per 
annum (C).
Figure 2 CT- TAVI scan acquisition protocols. Image acquisition protocols according to centre type (A). Phase of measurement 
reporting according to centre type (B). TAVI, transcatheter aortic valve implantation.
were reported by all centres (table 2). Interestingly, coro-
nary artery luminal stenosis severity was included in all 
CT- TAVI reports at 24% (n=9/38) of centres and some-
times reported in 50% (n=19/38) of centres. Compared 
with non- TAVI centres, TAVI centres were more likely to 
report minimum iliofemoral luminal diameter (n=25/26, 
96% vs n=7/12, 58%, p=0.003) and optimal tube angu-
lation for intervention (n=12/26, 46% vs n=1/12, 8%, 
p=0.02) (table 2). There were no significant differences 
in reporting parameters when compared by specialty.
‘Heart team’ dissemination of findings
A ‘Heart Team’ discussion involving a cardiac imaging 
specialist is more frequent in TAVI centres compared 
with non- TAVI centres (96%, n=24/25 vs 33%, n=4/12, 
p<0.001) (figure 3). However, to facilitate interpretation 
of CT- TAVI findings, a cardiac imaging specialist is ‘always 
present’ at 57% (n=16/28) of centres overall (54%, 
n=13/24 TAVI centres vs 75%, n=3/4 non- TAVI centres), 
and ‘most of the time’ at a further 21% (n=6/28) of 
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Table 1 Estimated contrast volumes and dose length product (DLP) for the last five CT- TAVI scans performed at each centre 
and radiation doses according to scan protocol
Overall TAVI centres (n=22) Non- TAVI centres (n=9) P value
Contrast volume (mL) 100 (80–130)
Min 50, max 170
95 (74–120)
Min 60, max 150
110 (88–160)
Min 50, max 170
0.06
DLP (mGy.cm) 675 (477–954)
Min 139, max 2000
550 (423–939)
Min 145, max 2000
700 (538–1075)
Min 139, max 1750
0.66
 
 
CT- TAVI scan protocol
Retrospective—whole cardiac 
cycle (n=12)
Prospective ECG- gated 
narrow padding (n=12)
Prospective ECG- gated wide 
padding (n=4)
DLP (mGy.cm) 882 (524–1688)* 423 (230–631) 921 (850–1138)**
Values are median and IQR.
*P=0.003, **p=0.002, both versus prospective ECG- gated narrow padding.
TAVI, transcatheter aortic valve implantation.
Table 2 Measurements and structures typically included in the CT- TAVI report at each centre
Overall (n=38)
TAVI centres 
(n=26)
Non- TAVI 
centres (n=12) P value
Aortic annulus circumference 21 (55%) 16 (62%) 5 (42%) 0.25
Aortic annulus area 24 (63%) 17 (65%) 7 (58%) 0.675
Aortic annulus diameter (perimeter derived) 23 (61%) 17 (65%) 6 (50%) 0.367
Aortic annulus diameter (area derived) 19 (50%) 13 (50%) 6 (50%) 1.0
Minimum short- axis measurement
Sinus of Valsalva diameter (cusp- cusp)
20 (53%) 14 (54%) 6 (50%) 0.82
Minimum short- axis measurement
Sinus of Valsalva diameter (cusp- commissure)
20 (53%) 13 (50%) 7 (58%) 0.63
Extent and distribution of aortic root calcification 31 (82%) 22 (85%) 9 (75%) 0.48
Number of valve cusps (eg, bicuspid, tricuspid) 32 (84%) 22 (85%) 10 (83%) 0.92
Distance (height) from aortic annulus to LMS ostium 30 (79%) 21 (81%) 9 (75%) 0.69
Distance (height) from aortic annulus to RCA ostium 30 (79%) 21 (81%) 9 (75%) 0.69
Distance (height) from aortic annulus to sinotubular junction (left cusp) 11 (29%) 6 (23%) 5 (42%) 0.24
Distance (height) from aortic annulus to sinotubular junction (right cusp) 9 (24%) 5 (19%) 4 (33%) 0.34
Distance (height) from aortic annulus to sinotubular junction (non- 
coronary cusp)
7 (18%) 4 (15%) 3 (25%) 0.48
Presence of LVH 23 (61%) 18 (69%) 5 (42%) 0.17
Ascending aorta diameter 31 (82%) 21 (81%) 10 (83%) 0.85
Descending and abdominal aorta (tortuosity, intraluminal obstruction, 
calcification)
31 (82%) 23 (88%) 8 (67%) 0.11
Subclavian and brachiocephalic artery diameter 18 (47%) 16 (62%) 2 (17%) 0.01
Minimum iliofemoral artery luminal diameter 32 (84%) 25 (96%) 7 (58%) 0.003
Iliofemoral artery patency 32 (84%) 24 (92%) 8 (67%) 0.04
Iliofemoral artery tortuosity 31 (82%) 24 (92%) 7 (58%) 0.01
Optimal tube angulation data to inform fluoroscopic projection for device 
deployment
13 (34%) 12 (46%) 1 (8%) 0.02
Values are count (n) and percentage (%).
Bold values indicate statistical significance at a p value <0.05
LMS, left main stem; LVH, left ventricular hypertrophy; RCA, right coronary artery; TAVI, transcatheter aortic valve implantation.
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Figure 3 Dissemination of findings to Heart Team. Heart Team multidisciplinary discussions were present at 76% of centres 
overall (A). When Heart Team discussions were in place, a cardiac imaging specialist was ‘always present’ at 57% of meetings 
(B). There was a significant difference in the provision of Heart Team meetings at TAVI and non- TAVI centres (96%, n=24/25 vs 
33%, n=4/12, p<0.001) (C). TAVI, transcatheter aortic valve implantation.
centres overall (21%, n=5/24 TAVI centres vs 25%, n=1/4 
non- TAVI centres). A cardiac imaging specialist is ‘never’ 
present at 11% (n=3/28) of centres (13%, n=3/24 TAVI 
centres vs 0%, n=0 non- TAVI centres).
dIsCussIOn
In this study, we found that only one in seven respondents 
perform a high annualised volume of CT- TAVI . As such, 
there is wide variation in practice among UK cardiac 
centres in the acquisition and reporting of CT- TAVI. 
Median radiation dose exposure was 675  mGy. cm in UK 
cardiac centres, however significant reductions in the 
DLP were obtained by using prospective ECG gating with 
narrow- padded acquisitions. To ensure optimal reporting 
standards in all UK cardiac centres, further collaboration 
between TAVI and non- TAVI centres should be encour-
aged.
Following the expansion of TAVI over the past decade, 
the provision of non- invasive cardiac imaging to support 
structural heart disease programmes can no longer be 
solely delivered in tertiary cardiac centres. This comes at 
a time when there has been considerable service expan-
sion in cardiac CT following the implementation of the 
revised National Institute for Health and Care Excel-
lence Clinical Guideline 95 (update 2016) necessitating 
that the UK, as a whole, provides over 350 000 cardiac CT 
angiograms per annum.8 This compares to the estimated 
42 340 scans reported by 198 accredited individuals on 
304 CTCA- capable scanners recently being performed.9 
This has resulted in even the highest volume cardiac CT 
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centres needing to double their service provision for 
coronary artery disease assessment, and thus hindering 
further expansion of cardiac CT in the assessment of struc-
tural heart disease in tertiary cardiac centres.9 However, 
an increasing number of new centres which offer cardiac 
CT has meant that experienced imaging cardiologists 
and radiologists can also provide lower numbers of 
CT- TAVI in house remote from TAVI centres, thereby 
performing CT- TAVI at a location which may be more 
convenient for the patient. Whether a ‘hub and spoke’ 
model that acquires CT imaging at the local centre and 
offers shared reporting with structural imaging specialists 
at TAVI centres will improve CT interpretation in non- 
TAVI centres is unknown. However, this model has been 
successfully employed in other collaborative networks 
using CT imaging.10
With respect to radiation dose, the ‘as low as reason-
ably achievable’ principle is a central tenant of legislation 
stating that ionising radiation should be optimised to use 
the minimum amount of radiation to attain adequate 
diagnostic information.11 For coronary CT angiography, 
the UK has the lowest international diagnostic reference 
levels set by Ionising Radiation (Medical Exposure) Regu-
lations at 380  mGy. cm for retrospective acquisitions with 
ECG gating and 170  mGy. cm for prospective acquisitions 
with no padding.12 Focusing attention on the optimal 
scan acquisition in the field of coronary CT angiography 
has resulted in many centres switching from retrospective 
to prospective acquisitions and reducing tube current 
potential, thereby reducing the median radiation expo-
sure by 78%.13 14 In this study, the wide variation in scan-
ning techniques for acquiring CT- TAVI data sets would 
suggest that there is scope to lower radiation dose expo-
sure through improved standardisation of practice across 
UK cardiac CT centres. Indeed, this would fall under the 
remit of the ‘Getting it right first time’ model that aims to 
reduce unwarranted variation in UK clinical practice. Of 
note, radiation doses reported by the members surveyed 
varied 14- fold between the lowest and highest reported 
DLPs (range 139–2000  mGy. cm). Some of this variation 
may be attributed to the perceived need to analyse the 
aortic annulus in both ventricular systole and diastole. 
While there is no consensus on the optimal acquisition 
technique, international guidelines advocate a prefer-
ence for systolic scan coverage, as this is when the aortic 
annulus is most circular and has the largest orifice area 
for accurate valve sizing.5 15 16 However, reverse dynamism 
of the interventricular septum which is frequently seen 
in patients with sigmoid hypertrophy may favour dimen-
sions measured in ventricular diastole, thus necessitating 
retrospective ECG- gated reconstructions throughout 
the entire cardiac cycle.5 Further investigation of the 
optimal CT- TAVI acquisition for routine clinical practice 
is warranted.
Decisions regarding TAVI are made in the context of 
a ‘Heart Team’ multidisciplinary discussion which draws 
on expertise from interventional cardiologists, cardiac 
surgeons and cardiac imaging specialists.17 While local 
institutions may differ in their approach to the compo-
sition of the ‘Heart Team’, it is unsurprising that these 
are more likely to occur in TAVI centres than non- TAVI 
centres. However, it is notable that despite the critical 
importance of CT- TAVI in the preprocedural planning 
of transcatheter heart valve procedures, there are some 
TAVI centres where a cardiac imaging specialist is never 
present to interpret the imaging findings in the clinical 
context. This may explain why the aortic annular dimen-
sion evaluation, a critical step for transcatheter aortic 
valve sizing, differs in the level of detailed reporting 
between sites. In order to maximise the information 
obtained from CT- TAVI scans both in terms of written 
reporting and dissemination to interventional cardiol-
ogists, cardiac imagers should be integrated into the 
‘Heart Team’ discussion. This would help address specific 
questions in CT- TAVI reporting, such as which parame-
ters constitute a mandatory minimum for a CT- TAVI 
report.18 In this regard, the observation that coronary 
artery stenosis assessment is performed in up to 50% of 
cardiac CT centres raises the question as to whether this 
should be routinely reported on CT- TAVI scans.19 20 The 
use of CT- TAVI to evaluate the patency of coronary artery 
bypass grafts and native coronary arteries is feasible, 
however as periprocedural medication (beta- blocker, 
glyceryl trinitrate) that is routinely administered for coro-
nary CT angiography is contraindicated in the setting of 
severe aortic stenosis, optimal images may not always be 
obtained.20 Interestingly, while selective beta- blockade 
has been used in the context of severe asymptomatic21 
and symptomatic aortic stenoses,22 there is a paucity of 
evidence supporting the safety of intravenous metopr-
olol administration during CT- TAVI acquisition. If beta1- 
selective blockade is to be considered on an individual 
basis, the patient should be counselled on the risks of 
exacerbating symptoms related to aortic stenosis. Medica-
tion use at the time of CT- TAVI will be explored in more 
detail in future studies.
There are some limitations to this study. Despite attempts 
to obtain responses from UK cardiac CT centres, some 
centres that perform CT- TAVI were not captured. More-
over, the survey only elicited responses (response rate 
only 12%) from members of the BSCI, meaning that an 
unknown but likely significant number of those reporting 
CT- TAVI, for example, interventional cardiologists, have 
not been captured. This introduces bias and influences 
the external validity of the data, while reliance on self- 
reporting of data may also introduce error. Furthermore, 
some responses from different individuals originated 
from the same centre. Because these data were frequently 
discordant, reflecting intracentre variation, we elected 
to include all responses from all respondents, which is 
also a source of bias. The image quality of CT- TAVI scans 
obtained at UK cardiac CT centres was not analysed in this 
study, but we presume that each centre obtains diagnostic 
CT- TAVI images on the majority of occasions. Finally and 
perhaps most importantly, no data on complications 
following CT- TAVI (eg, contrast- induced nephropathy) 
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were collected. Future studies exploring the relationship 
between CT- TAVI, periprocedural complications and 
patient outcomes would be instructive and could inform 
optimal CT- TAVI scan acquisition protocols.
COnClusIOn
This national survey formally describes current CT- TAVI 
practice in the UK. High- volume activity was only present 
at one in seven cardiac CT centres. There is wide vari-
ation in scan acquisition, scan reporting and radiation 
dose exposure in cardiac CT centres.
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